Last reviewed · How we verify
NCT06819839
Community-led Strategy to Reduce Cardiovascular Disease Risk Among Conflict-affected Populations
NA trial testing Village Health Worker (VHW) Care Model in Cardiovascular Diseases in 213 participants. Completed in 30 June 2025.
30 April 2025
Quick facts
| Lead sponsor | Community Partners International |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 213 |
| Start date | 27 October 2024 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Burma |
Drugs / interventions tested
- Village Health Worker (VHW) Care Model
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Hypertension — all drugs for Hypertension →
- Diabetes — all drugs for Diabetes →
Sponsor
Community Partners International
Who can join
Adults 40 to 100, any sex, with Cardiovascular Diseases or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to test a village health worker (VHW) based care model to reduce cardiovascular risk among adults in areas of eastern Myanmar affected by armed conflict. All individuals aged 40 years and above will be invited to participate in this study. Participants will be checked whether they have a history of cardiovascular disease, diabetes (high blood sugar), high blood pressure or risk of developing cardiovascular disease by asking for medical history, measuring blood pressure, weight and height, and blood glucose if necessary. The main question the study aims to answer is: Does villagers residing in the VHW supported villages have their blood pressure controlled, adherent to therapy and subsequently reduce the risk of developing cardiovascular disease after 5 months of monthly VHW home visits?
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Village Health Worker Intervention to Reduce Cardiovascular Disease Risk in Remote Areas of Armed Conflict in Myanmar – Results from a Feasibility Study in Three Villages
Ramachandran A, Thwe SM, Win CZ, Htet NL, et al · · 2025 · cited 1× · DOI 10.21203/rs.3.rs-7384010/v1 -
A village health worker intervention to reduce cardiovascular disease risk in remote areas of armed conflict in Myanmar-results from a feasibility study in three villages.
Ramachandran A, Thwe SM, Win CZ, Htet NL, et al · · 2026 · PMID 41834041 · DOI 10.1186/s13031-026-00785-2
Verify or expand the search:
- PubMed search for NCT06819839
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06819839 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Community Partners International
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06819839.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing